Since we found that CDK2 antagonism opposed centrosome clustering (18–21), combining such an inhibitor with a PLK4 inhibitor that we reported to promote supernumerary centrosomes (46) could reduce proliferation and augment apoptosis in polyploid cancer cells. The gene discussed is CDK2; the disease is cancer.